Literature DB >> 18661541

Investigation of freezing- and thawing-induced biological, chemical, and physical changes to enoxaparin solution.

Rahul P Patel1, Christian Narkowicz, Glenn A Jacobson.   

Abstract

This study investigated the effect of freezing and thawing on the biological, physical, and chemical properties of enoxaparin solution. Solutions were frozen and thawed under different conditions, in the presence or absence of dimethyl sulfoxide (DMSO) or 1,2-propanediol (1,2-PD), and the antifactor Xa (AFXa) activity was determined. Enoxaparin solution lost more than 60% of its AFXa activity when thawed rapidly after freezing at -196 degrees C. The loss of AFXa activity was less with higher freezing temperatures and increased with the number of freeze/thaw cycles, but was independent of the duration of freezing. Slow freezing to -196 degrees C with rapid thawing, or rapid freezing with slow thawing, resulted in negligible loss of AFXa activity. The loss of AFXa activity did not involve the loss of N-sulfate groups, the breakdown of glycosidic bonds or the glassy state transition. Controlling the freezing or thawing conditions, dilution with water or addition of a small percentage of DMSO ameliorated the loss of enoxaparin AFXa activity. The loss in AFXa activity was found by size exclusion chromatography to be primarily due to aggregation and was reversed by sonication in the presence of DMSO. These results may provide insight into solutions for the long-term storage of concentrated or diluted enoxaparin. (c) 2008 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18661541     DOI: 10.1002/jps.21483

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin.

Authors:  Madhur D Shastri; Niall Stewart; James Horne; Gregory M Peterson; Nuri Gueven; Sukhwinder S Sohal; Rahul P Patel
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

2.  Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics.

Authors:  Madhur D Shastri; Niall Stewart; Mathew Eapen; Gregory M Peterson; Syed Tabish R Zaidi; Nuri Gueven; Sukhwinder Singh Sohal; Rahul P Patel
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

Review 3.  Therapeutic Potential of Enoxaparin in Lichen Planus: Exploring Reasons for Inconsistent Reports.

Authors:  Rahul P Patel; Madhur D Shastri; Long Chiau Ming; Syed Tabish R Zaidi; Gregory M Peterson
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

4.  Hemocompatibility Evaluation of Thai Bombyx mori Silk Fibroin and Its Improvement with Low Molecular Weight Heparin Immobilization.

Authors:  Tanrada Fungmongkonsatean; Jirapas Jongjitwimol; Pussadee Paensuwan; Teonchit Nuamchit; Duangduan Siriwittayawan; Sorada Kanokpanont; Siriporn Damrongsakkul; Piyanuch Thitiwuthikiat
Journal:  Polymers (Basel)       Date:  2022-07-20       Impact factor: 4.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.